Balance Medical released its 2026 interim report. Total operating revenue was 254 million yuan, and net profit attributable to the parent company was 43.8859 million yuan, down 38.54% from the same period last year. Net cash inflow from operating activities was 495,200 yuan, down 99.34% year-on-year. The company's asset-liability ratio was 15.10%, gross margin was 88.71%, ROE was 3.50%, and diluted earnings per share was 0.32 yuan. The number of shareholders was 5,083, and the top ten shareholders held 79.52% of the total share capital.
Beijing Balance Medical Technology Co LtdNet profit fell 38.54% year-on-year, with operating cash flow down 99.34%.
